Huang Kai, Gao Jia-Ming, He Shuang, Zhu Yan
State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 300193, China Chinese Medicine New Drug Research and Development Center, Tianjin International Biomedical Research Institute Tianjin 300457, China.
Zhongguo Zhong Yao Za Zhi. 2020 May;45(9):2082-2090. doi: 10.19540/j.cnki.cjcmm.20200313.401.
As the final destination of various cardiovascular abnormalities, heart failure is one of the diseases with the highest morbidity and mortality in the world. Due to its complicated pathogenesis, people urgently need to find new targets and effective treatment. Imbalance in myocardial energy metabolism, an important molecular biological basis for heart failure, affects the contractile and diastolic functions of the heart. As the main source of energy synthesis in cardiomyocytes and an important participant in various signaling pathways, mitochondria plays an indispensable role in the process of cell survival and death and has been considered as a critical target for the treatment of heart failure. Traditional Chinese medicine has a great effect on the treatment of heart failure through multi-components, multi-targets, and multi-channels. In recent years, more and more researches regard mitochondria as the target of traditional Chinese medicine in the treatment of heart failure, and have achieved significant results in improving mitochondrial function, increasing energy metabolism and energy supplement for cardiomyocytes, and resisting against oxidative stress. In this article, researches on the regulation of mitochondria in the treatment of heart failure by traditional Chinese medicine are reviewed from four aspects: mitochondrial biogenesis; mitochondrial electron transport chain and reactive oxygen species(ROS) production; metabolic substrates and metabolic enzymes; and calcium ion transport in the mitochondria. It provides a basis for further research and clinical application in the future.
作为各种心血管异常的最终归宿,心力衰竭是全球发病率和死亡率最高的疾病之一。由于其发病机制复杂,人们迫切需要寻找新的靶点和有效的治疗方法。心肌能量代谢失衡是心力衰竭的重要分子生物学基础,影响心脏的收缩和舒张功能。线粒体作为心肌细胞能量合成的主要来源以及各种信号通路的重要参与者,在细胞存活和死亡过程中发挥着不可或缺的作用,被认为是治疗心力衰竭的关键靶点。中药通过多成分、多靶点、多途径对心力衰竭的治疗具有显著疗效。近年来,越来越多的研究将线粒体作为中药治疗心力衰竭的靶点,在改善线粒体功能、增加心肌细胞能量代谢和能量补充以及抵抗氧化应激方面取得了显著成果。本文从线粒体生物发生、线粒体电子传递链与活性氧(ROS)产生、代谢底物与代谢酶以及线粒体钙离子转运四个方面综述了中药对心力衰竭治疗中线粒体调控的研究。为今后进一步的研究和临床应用提供依据。